Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC–MS/MS
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference33 articles.
1. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases;Willrich;Transl. Res.,2015
2. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms;Ordas;Clin. Pharmacol. Ther.,2012
3. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease;Doherty;Inflamm. Bowel Dis.,2012
4. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study;Wu;Clin. Ther.,2014
5. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease;Baert;N. Engl. J. Med.,2003
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in analytical technologies for emerging drug modalities and their separation challenges in LC-MS systems;Journal of Chromatography A;2024-09
2. Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation;The AAPS Journal;2024-07-24
3. Improved high‐performance liquid chromatography tandem mass spectrometry method for quantification of infliximab in pediatric plasma and its application in therapeutic drug monitoring;Rapid Communications in Mass Spectrometry;2024-07-10
4. High-throughput, low-cost quantification of 11 therapeutic antibodies using caprylic acid precipitation and LC-MS/MS;Analytica Chimica Acta;2024-07
5. Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround time;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3